Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma have?
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma has 217 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma published?
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma has 2017 year in the ScholarIQ index.
What is the open-access status of Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma?
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma?
The DOI for Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma is on the source record.
What is the PMID of Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma?
The PMID for Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma is on the source record.
What is the OpenAlex record for Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma?
The OpenAlex for Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma is on the source record.